Tenon Medical prices $4.2M offering of shares and warrants
Tenon Medical, Inc. has priced a public offering of up to 11,052,631 shares of common stock and warrants to purchase 13,263,159 shares for aggregate gross proceeds of approximately $4.2 million. The securities are offered at a combined public offering price of $0.38 per share. Net proceeds will be used for partial repayment of convertible notes and commercial expansion.
*this image is generated using AI for illustrative purposes only.
Tenon Medical, Inc. has priced a public offering of securities for aggregate gross proceeds of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses. The offering consists of up to 11,052,631 shares of common stock, par value $0.001 per share, together with common stock purchase warrants to purchase up to 13,263,159 shares of common stock. The securities are offered at a combined public offering price of $0.38 per share of common stock and accompanying Common Warrants.
The Common Warrants will be immediately exercisable, entitling the holder to purchase one share of common stock at an exercise price of $0.38 per share. Pre-funded warrants, if issued in lieu of common stock, are exercisable at $0.001 per share. The common stock and Common Warrants are being sold together in this offering but will be issued separately.
Tenon Medical expects to use the net proceeds for partial repayment of outstanding convertible notes. Funds will also support the expansion of the commercial footprint of its product portfolio, including training clinicians and hiring additional direct sales representatives. The company plans to expand its external distribution network and continue clinical research studies to support reimbursement efforts.
Offering Details
| Component | Details |
|---|---|
| Gross Proceeds | $4.2 million |
| Common Stock Shares | Up to 11,052,631 |
| Common Warrants Shares | Up to 13,263,159 |
| Combined Public Offering Price | $0.38 per share |
| Warrant Exercise Price | $0.38 per share |
| Pre-Funded Warrant Exercise Price | $0.001 per share |
WallachBeth Capital LLC is acting as the sole placement agent for the offering. Sichenzia Ross Ference Carmel LLP served as legal counsel to Tenon Medical, while Sheppard, Mullin, Richter & Hampton LLP acted as counsel to WallachBeth Capital LLC.
The securities are being offered pursuant to a registration statement on Form S-1 (File No.: 333-296952) and a registration statement on Form S-1MEF (File No.: 333-297142), which were declared effective by the Securities and Exchange Commission.
How will the repayment of convertible notes impact Tenon Medical's debt obligations and financial flexibility?
What specific markets or regions is Tenon Medical targeting for its commercial footprint expansion?
How will the issuance of additional shares and warrants affect existing shareholders' equity and stock price?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
